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BDNF Regulates Reelin Expression
and Cajal-Retzius Cell Development
in the Cerebral Cortex
subplate, as well as all previous layers of the cortical
plate, until they reach the marginal zone, which remains
the outermost layer of the cortex. This process gener-
ates the characteristic ªinside-outº organization of the
layers in the cortical plate, with younger neurons in the
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the formation of the inside-out layer organization of theKarolinska Institute
cerebral cortex. In reeler mutant mice, which lack ex-171 77 Stockholm
pression of Reelin (D'Arcangelo et al., 1995; Hirotsune§Section of Restorative Neurology
et al., 1995), cortical layering is grossly abnormal: mi-Wallenberg Neuroscience Center
grating neurons fail to split the preplate and instead lineUniversity Hospital
up below it, in the same order as that in which they areS-22185 Lund
born (Caviness, Jr., 1982; Goffinet, 1984; Caviness, Jr.,Sweden
et al., 1988). As a result, the reeler cortex lacks an identi-
fiable subplate as well as a proper marginal zone, and
cortical layering is reversed, as compared with normalSummary
animals. The reeler mutation also causes abnormalities
in the hippocampus (Caviness and Sidman, 1973; Stan-Cajal-Retzius (CR) cells of the cerebral cortex express
field and Cowan, 1979), the cerebellum (Goffinet et al.,receptors for the neurotrophin brain-derived neuro-
1984), and the olfactory bulb (Wyss et al., 1980), indicat-trophic factor (BDNF) and downregulate expression
ing that Reelin plays a crucial role in the histogenesisof the extracellular matrix protein Reelin during early
of several laminated structures in the mammalian brain.postnatal development, coincident with the onset of
The molecular mechanisms by which Reelin regulatescortical BDNF expression. During this period, mice
cell migration are, however, unknown. Mutations in thelacking BDNF have elevated levels of Reelin in CR
mouse gene mdab, encoding a target of Src-like proteincells. Acute BDNF stimulation of cortical neuron cul-
tyrosine kinases, produce a phenotype that is indistin-tures and overexpression of BDNF in the developing
guishable from reeler (Howell et al., 1997; Sheldon etbrain of transgenic mice prior to the onset of endoge-
al., 1997), suggesting that the protein encoded by mdabnous production causes a profound, dose-dependent
may be part of a downstream signaling pathway forreduction of Reelin expression in CR cells. In addition,
Reelin.overexpression of BDNF produces gaps and hetero-
During postnatal brain development, and concomitanttopias in the marginal zone and disorganization and
with the completion of cortical lamination, Reelin ex-aggregation of cortical CR cells and induces several
pression is downregulated in cortical CR cells (Schiff-other malformations, including aberrant cortical lami-
mann et al., 1997). Downregulation of Reelin expressionnation, similar to the phenotype of reeler mutant mice,
is followed by the disappearance of CR cells, which inwhich lack Reelin. These results demonstrate a role
the murine neocortex occurs during the second and
for BDNF on cortical CR cells and identify Reelin as a
third postnatal weeks (Derer and Derer, 1990; Del Rio
direct effector of this neurotrophin during brain devel-
et al., 1995). However, the actual fate of CR cells has
opment. been controversial: cell dilution, neuronal death, and
transformation into nonpyramidal neurons have been
Introduction
proposed as possible outcomes (Parnavelas and Ed-
munds, 1983; Del Rio et al., 1995, 1996). Morphological,
Neuronal migration and lamination in developing cere- histochemical, and fate analyses have presented evi-
bral cortex depend upon secreted signals, including the dence for postnatal CR cell death in the cerebral cortex
extracellular matrix protein Reelin, which is produced (Derer and Derer, 1990; Del Rio et al., 1995, 1996), al-
by a transient subpopulation of pioneer neurons, the though it is unclear whether all or only part of the CR
Cajal-Retzius (CR) cells (D'Arcangelo et al., 1995; Hiro- cell population is eliminated by this process. It has also
tsune et al., 1995; Ogawa et al., 1995; Pearlman and been proposed that some CR cells remain in the adult
Sheppard, 1996; Del Rio et al., 1997; Soriano et al., brain (Liu et al., 1996). The factors and molecular mecha-
1997). CR cells are first observed during early cortical nisms that regulate CR cell development and Reelin
development in a primordial layer knownas the preplate. expression are totally unknown.
The subsequent migration of neurons from the subven- The neurotrophins are a family of structurally and
tricular zone into the cortex divides the preplate into an functionally related polypeptides that control the differ-
inner layer, the subplate, and an outer layer, or marginal entiation, survival, and maintenance of developing and
zone, rich in CR cells. Successive waves of newly born adult vertebrate neurons (Lewin and Barde, 1996). Tar-
neurons migrate into the cortex, passing through the geted disruption of individual neurotrophin genes results
in the nearly complete ablation of distinct subpopula-
tions of peripheral neurons (Crowley et al., 1994; Ernfors‖ To whom correspondence should be addressed.
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Figure 1. Elevated Reelin Expression in Cor-
tical CR Cells of Mice Lacking BDNF
(A) Quantification of Reelin mRNA levels per
cell in postnatal marginal zone cells of wild-
type (wt) (open squares) and BDNF2/2 (closed
squares) mice. Results are presented as per-
centage of wild-type at P0 (mean 6 SD of
more than 60 cells examined). Superimposed
in the graph is the expression profile of BDNF
mRNA in the cerebral cortex (grey circles),
adapted with permission from Timmusk et al.
(1994).
(B) Number of Reelin-expressing cells in mar-
ginal zone of BDNF2/2 mice. Values are
presented as percentage of wild-type (n 5 5).
*p , 0.01.
(C and D) Dark field autoradiograms of Reelin
mRNA in situ hybridization through the cortex
of P11 wild-type (C) and BDNF2/2 (D) mice.
Scale bar, 200 mm.
et al., 1994a, 1994b, 1995; FarinÄ as et al., 1994; Jones et complemented by experiments on Reelin-positive corti-
cal neurons in culture and, together, demonstrate a roleal., 1994), underscoring the importance of neurotrophins
as physiological target-derived survival factors in the for BDNF as a negative regulator of Reelin expression
and a signal for CR cell development.peripheral nervous system. In contrast, the survival of
many subpopulations of central neurons known to ex-
press neurotrophin receptors and to respond to exoge- Results
nous neurotrophins in vitro and in vivo is not com-
promised by disruption of neurotrophin genes. Initial Elevated Reelin Expression in Cortical CR Cells
of Mice Lacking BDNFstudies on developing central neurons of neurotrophin
knockout mice were hampered by the relatively short Previous studies (Marty et al., 1996; Brunstrom et al.,
1997) and our own data (see below) indicate that CRsurvival times of these animals, typically of a few days
after birth. By extending the survival of these animals for cells express TrkB receptors and have the capacity to
respond to BDNF, suggesting that this neurotrophinup to 2±3 weeks and combining several gene mutations,
more recent studies have revealed that neurotrophins, could act directly on these cells to regulate gene expres-
sion and survival. During normal development, very lowin particular brain-derived neurotrophic factor (BDNF)
and its receptor tyrosine kinase TrkB, are necessary for BDNF expression can first be detected in the rodent
brain at embryonic day 13 (E13), with little change untilthe survival of neurons in several regions of the postnatal
brain, including the hippocampus, cortex, basal fore- the second postnatal day (P2), after which BDNF levels
increase rapidly, with a peak at P14 (Friedman et al.,brain, and cerebellum (Minichiello and Klein, 1996; Al-
cantara et al., 1997; Fagan et al., 1997; Schwartz et al., 1991; Timmusk et al., 1994). This pattern of expression
is even more pronounced in the cerebral cortex, where1997). Nevertheless, the reductions in neuron number
reported so far have been relatively mild, and in no case BDNF is virtually undetectable before birth (Timmusk et
al., 1994). BDNF upregulation coincides with the timehas mutation of a neurotrophin or trkgene resulted in the
complete disappearance of an anatomically or chemi- course of decline in Reelin levels and the disappearance
of CR cells that occur during the normal developmentcally distinct subpopulation of central neurons. Taken
together, the available data on the developmental roles of the postnatal rodent brain (Derer and Derer, 1990;
Schiffmann et al., 1997), suggesting that BDNF couldof neurotrophins and their receptors in the central ner-
vous system suggest the existence of redundant sur- be involved in several of these events.
We examined Reelin mRNA expression in CR cells ofvival pathways or alternative roles for neurotrophins in
central neurons, such as in the control of gene expres- the marginal zone in brains of wild-type and BDNF2/2
mice at P0, P5, P11, and P18 by in situ hybridization.sion and cell fate.
The work presented here addresses the role of BDNF Levels of Reelin mRNA expression per cell were quanti-
fied by image analysis of hybridized tissue sections. Noin the development and function of cortical CR cells.
For this purpose, we have examined CR cells in BDNF difference in the levels of Reelin mRNA per cell could
be detected between wild-type and BDNF2/2 mice atknockout mice during the initial period of expression of
this neurotrophin in the postnatal cerebral cortex and P0 (Figure 1A), when levels of BDNF mRNA in normal
cerebral cortex are still below detection levels (Timmuskin transgenic mice overexpressing BDNF prior to the
onset of endogenous production. These studies were et al., 1994). However, elevated levels of Reelin mRNA
BDNF as a Negative Regulator of Reelin Expression
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Figure 2. BDNF Downregulates Reelin Expression in Dissociated Cultures of Cortical Neurons
(A±C) Phase contrast photomicrographs of dissociated cultures of E16 rat cortical neurons stained with an anti-Reelin monoclonal antibody.
Arrows indicate Reelin-positive neurons. Note that the staining is confined to one half of the cell soma.
(A) Control culture.
(B) Culture treated with 50 ng/ml BDNF for 5 days.
(C and D) Close-up view of a Reelin-expressing neuron from untreated cultures. Reelin immunoreactivity was also found in the axon, in a
punctated pattern (arrowheads).
(D) Double-staining immunohistochemistry of Reelin (grey) and TrkB (red) in neuronal cultures. Arrows indicate double-labeled cells; note the
characteristic staining pattern of Reelin, distinct from that of TrkB, which extended over the whole cytoplasm. Arrowheads denote several
unlabeled cells.
(E) Quantification of Reelin immunoreactivity in dissociated cultures of cortical neurons after second treatments with BDNF and NT-4. Reelin
staining intensity of 10 cells in each of six different wells (n 5 6) was scored by an observer who was blind to the treatments made to the
cultures. Similar results were obtained by a second observer. Results are presented as the average number of cells scoring low, medium,
and high in Reelin intensity (see Experimental Procedures). All factors were tested at 50 ng/ml.
(F) Autoradiogram of an RPA for Reelin mRNA of dissociated cultures of cortical neurons treated for 5 days with 50 ng/ml BDNF. The bottom
panel shows the corresponding signal for glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which was used to normalize for different
amounts of RNA. Lanes 1, 2 , 3, and 4 correspond to duplicate experiments.
(G) Phosphorimager quantitation of RPA for Reelin mRNA of dissociated cultures treated with neurotrophins. Values (average of two experi-
ments 6 SD) are expressed in arbitrary units and standardized to the signal obtained with the GAPDH riboprobe.
were seen in marginal zone cells of BDNF2/2 mice, com- downregulation of Reelin expression in cells of the mar-
ginal zone and that, in addition, this neurotrophin maypared with wild-type, at both P5 and P11 (Figures 1A,
1C, and 1D), coincident with the onset of BDNF mRNA be a survival factor for a subpopulation of Reelin-posi-
tive cells at later stages ($P11) of postnatal devel-expression in normal cortex (Timmusk et al., 1994). Thus,
while Reelin expression declined steadily in wild-type opment.
mice, high levels were maintained in the cortex of BDNF
knockout mice during the first two postnatal weeks, BDNF Downregulates Reelin Expression in Cortical
Neurons in Cultureindicating a protracted period of Reelin expression in
the absence of BDNF. During this period, no significant We investigated further the possibility that Reelin is a
direct target gene of BDNF by studying the responsesdifferences in the number of cells expressing Reelin
mRNA could be seen between wild-type and BDNF2/2 of cortical neurons in culture to acute BDNF treatment.
Dissociated cultures of E16 rat cerebral cortex weremice (Figure 1B). However, a significant decrease in the
number of Reelin-positive cells was observed in the exposed to BDNF for either 12 hr, 2 days, or 5 days,
after which Reelin expression was studied by RNasemarginal zone of BDNF-/- mice at P18, about the longest
survival time of these animals (Figure 1B). At this time, protection assay (RPA) and immunocytochemistry. At
this time of development, all Reelin-positive neurons inthe surviving Reelin-positive cells in the marginal zone
of BDNF2/2 mice expressed lower (i.e., comparable to the cerebral cortex are confined to the marginal zone.
An anti-Reelin monoclonal antibody stained several neu-wild-type) levels of Reelin mRNA (Figure 1A), perhaps a
consequence of the process of the degeneration of rons of a characteristic bipolar morphology in these
cultures (Figures 2A and 2B). Intriguingly, staining in thethese cells in the absence of BDNF. Together, these data
suggested that BDNF is required for the developmental axons was punctated (Figure 2C), and in the cell body,
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Reelin staining was confined to one half of the cell soma
(Figure 2C). Importantly, double-staining experiments
indicated that Reelin-positive cells in these cultures ex-
pressed the BDNF receptor TrkB (Figure 2D). BDNF
treatment reduced Reelin staining in these cultures at
all three time points tested without affecting the total
number of Reelin-positive cells (Figure 2E and data not
shown). Blind scoring of staining intensity by two inde-
pendent observers showed that BDNF increased the
proportion of cells expressing low levels of Reelin,
whereas it decreased the proportion of highly express-
ing cells (Figure 2E). Neurotrophin-4 (NT-4), another neu-
rotrophin agonist of the TrkB receptor, had a compara-
ble effect on BDNF (Figure 4E), while neurotrophin-3
(NT-3), which predominantly acts via the TrkC receptor,
was not different from control (data not shown). BDNF
also downregulated Reelin mRNA expression in these
cultures at all three time points to about 50% of control
levels, as assessed by RPA (Figures 2F and 2G). The
relatively rapid kinetics of this regulation suggest direct
effects of BDNF on Reelin-expressing cells. A compara-
ble downregulatory effect on Reelin mRNA was also
seen after the second treatment with NT-4 (Figure 2G).
Combined, these data suggest that activation of TrkB
receptors by either BDNF or NT-4 can directly regulate
Reelin expression in developing neurons of the cerebral
cortex.
Reduced Reelin Expression in CR
Cells of Transgenic Mice
Overexpressing BDNF
Our data on BDNF2/2 mice and cortical neurons in cul-
ture indicated that Reelin is a direct effector of BDNF
during normal development, and, although in vivo this
Figure 3. Elevated Expression of BDNF mRNA inthe Brain of nestin±neurotrophin would normally act on Reelin expression
BDNF Transgenic Micepostnatally, our in vitro data clearly showed that BDNF
(A) Coronal section of the E15.5 brain of a nestin±BDNF transgenicis also capable of affecting Reelin levels in embryonic
mouse hybridized in situ with an antisense BDNF riboprobe.neurons. These observationsprompted us to investigate
(B) Coronal section of an E15.5 control brain.the effects of a premature exposure to BDNF on Reelin
(C) Sagittal section of an E15.5 transgenic brain. (A) and (B) were
expression, CR cell development, and cortical lamina- prepared simultaneously under comparable conditions. Abbrevia-
tion in the brains of transgenic mice overexpressing tions: SVZ, subventricular zone; HI, hippocampus; CTX, cerebral
BDNF prior to the onset of endogenous production. nes- cortex; VZ, ventricular zone; DG, dentate gyrus; LV, lateral ventricle;
IIIV, third ventricle. Scale bar, 400 mm.tin±BDNF transgenic mice overexpress BDNF under the
control of the promoter and enhancer regions of the
nestin gene, an intermediate filament gene widely ex-
pressed in neuronal precursors and developing neurons brain homogenates, as determined by two-site enzyme
immunoassay, vary between 10 and 60 ng/g tissue inthroughout the central and peripheral nervous systems
(Zimmerman et al., 1994; Dahlstrand et al., 1995). Mouse different transgenic embryos, while the level of BDNF
in total brain homogenates from control animals is inembryos expressing the nestin±BDNF transgene have
a normal external appearance throughout gestation but the order of 1±2 ng/g tissue.
We examined the expression of Reelin mRNA anddie shortly before or right after birth of what appears to
be a cardiorespiratory malfunction (T. R. and C. F. I., protein in the brains of nestin±BDNF transgenic mice
by in situ hybridization and immunohistochemistry. Inunpublished data). Most transgenic embryos show sig-
nificantly higher levels of BDNF mRNA in the brain than contrast to control mice, which showed a continuous
band of cells expressing high levels of Reelin mRNAcontrol littermate animals, primarily in the ventricular
zone and cerebral cortex (Figure 3). The peak of BDNF (Figures 4A and 4C), labeling was lower and sparser in
the marginal zone of E18.5 transgenic mice (Figures 4BmRNA expression in the brain is seen between E14.5
and E15.5; levels of expression vary by a factor of z10 and 4E). In agreement with the mRNA data, levels of
Reelin protein were greatly reduced in the marginal zonebetween different transgenic embryos, probably owing
to differences in transgene integration site and copy of transgenic mice (Figures4G and 4H). At higher magni-
fication, several cells expressing Reelin mRNA formednumber, as each embryo arises from an independent
pronuclear injection. At E14.5, BDNF protein levels in clusters in the marginal zone (Figures 4E and 4F). The
BDNF as a Negative Regulator of Reelin Expression
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Figure 4. Reduced Reelin Expression in CR
Cells of Transgenic Mice Overexpressing
BDNF
(A and C) In situ hybridization of coronal sec-
tions through a normal E18 mouse brain. Note
the uniform labeling of Reelin mRNA in the
marginal zone (arrow). Scale bar, 400 mm.
(B and E) Lower and sparse Reelin mRNA
labeling in the marginal zone of E18.5 trans-
genic mice.
(D) Reelin mRNA±expressing cells in normal
cortex. Scale bar, 80 mm.
(F) Reelin mRNA±expressing cells of aberrant
morphology in invaginations of the marginal
zone in transgenic mice.
(G) Reelin immunohistochemistry in normal
cortex. Scale bar, 400 mm.
(H) Reduced Reelin protein levels in trans-
genic cortex. Arrows point to an invagination
in the transgenic marginal zone. The pres-
ence of marginal zone cells in this segment
of transgenic cortex was confirmed indepen-
dently by calretinin and cresyl violet staining
(data not shown).
low levels of Reelin mRNA expression in the cortex of marginal zone (Figure 6D), similar inappearance to those
previously reported to be induced by exogenous admin-transgenic mice could not satisfactorily be accounted
for by a decrease in the number of cells expressing istration of NT-4 (Brunstrom et al., 1997). In addition to
invaginations and heterotopias, portions of the cortexReelin mRNA, as this was not significantly reduced,
compared with controls (data not shown). We therefore of transgenic mice were devoid of marginal zone (Figure
6C). Less pronounced and less abundant defects werequantified the level of Reelin mRNA per cell and found,
on average, a 50% reduction of expression in cells of also seen in the brains of E15.5 transgenic mice, while
E18 transgenic mice, a value that was in good agreement
with the data that we obtained in vitro. Quantification
of the levels of BDNF mRNA in the same transgenic
embryos revealed a strong negative correlation between
BDNF and Reelin mRNA levels in CR cells of nestin±
BDNF mice (Figure 5), thus bringing further support to
the notion that BDNF is a negative regulator of Reelin
expression.
Morphological Abnormalities in the Cortex
of nestin±BDNF Transgenic Mice
Next, we investigated the effects of BDNF overexpres-
sion and Reelin downregulation in the brains of nestin±
BDNF mice. Histological analysis of sections from E18.5
transgenic brains revealed a grossly aberrant cortical
architecture. Fifteen of 17 transgenic animals analyzed
at this age showed multiple microgyric sulcus forma-
tions consisting of invaginations of the marginal zone
into the underlying cortical plate (Figure 6B). The invagi-
nations distorted the normal radial architecture of the
underlying cells, which instead oriented themselvesper- Figure 5. Correlation between Reelin and BDNF mRNA Expression
in Marginal Zone Cells of E18 Transgenic Mice Overexpressing Dif-pendicular to the sides of the sulci. The depth and abun-
ferent Amounts of BDNFdance of the invaginations varied among different trans-
The level of Reelin mRNA per cell in marginal zone cells is plottedgenic animals and correlated with the level of BDNF
against the corresponding BDNF mRNA levels per cell measured inmRNA expressed in each embryo. Cells within these
the same brains (see Experimental Procedures for details). Reelininvaginations were found to expressmRNA for theBDNF
mRNA levels are expressed relative to those of wild-type mice;
receptor TrkB (Figure 6E) and expressed reduced levels BDNF mRNA levels are in arbitrary units. Wild-type and four
of Reelin protein (Figure 4H, arrows). In a few cases, transgenic embryos are indicated. Values are expressed as mean 6
SEM of more than 60 cells analyzed.heterotopic collections of cells were observed in the
Neuron
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Figure 6. Morphological Abnormalities in the Cortex of nestin±
BDNF Transgenic Mice
(A) Cresyl violet staining of a section through the cortical plate of a
normal E18.5 mouse brain. The marginal zone (MZ) is indicated.
Scale bar, 200 mm. Figure 7. Abnormal Organization and Morphology of CR Cells in
(B) Cortical plate in an E18.5 nestin±BDNF mouse. Note the pro- nestin±BDNF Transgenic Mice
nounced invaginations of the marginal zone (arrows). Scale bar,
(A) Calretinin immunohistochemistry of a section through a normal
200 mm.
E18.5 brain. Note the pronounced labeling in the marginal zone
(C) Portion of the cortical plate of a transgenic brain. Note the ab-
(arrow). Scale bar, 400 mm.
sence of marginal zone.
(B) Discontinuous calretinin labeling in the marginal zone of E18.5
(D) Heterotopic collection of cells in the marginal zone of a
transgenic mice.
transgenic mouse brain (arrow).
(C) Close-up view of calretinin-positive cells in the marginal zone
(E) TrkB mRNA expression in cell bodies within invaginations of the
of control mice. Note the horizontal arrangement of CR cells andmarginal zone in E15.5 transgenic mice (arrows). Scale bar, 80 mm.
their processes. Scale bar, 80 mm.
(D) Close-up view of calretinin-positive cells from E18.5 transgenic
mice (area indicated by arrow in [B]). Note the aberrant organization
and morphology of CR cells.no abnormalities were seen at E12.5 (data not shown),
(E) A less affected transgenic animal showing a more uniform distri-indicating a progressive increase in the severity of the
bution of calretinin labeling, but with loose bundles of calretinin-
phenotype over time. No cortical malformations were positive fibers entering into the cortical plate (arrow).
seen in nestin±NT-3 mice, which overexpress another (F) Cortical plate of a transgenic mouse brain with marginal zone
member of the neurotrophin family (Ringstedt et al., invaginations (arrows), visualized by cresyl violet staining. Scale bar,
400 mm.1997), indicating that the effects seen with BDNF were
(G) Calretinin staining of a section adjacent to the one shown innot caused by nonspecific overexpression of any neuro-
(F), visualized by immunofluorescence. Note the correspondencetrophic factor.
between marginal zone invaginations and clusters of calretinin-posi-
tive cells (arrows).
(Inset) Calretinin-positive cell bodies and fibers fill the cavity of theAbnormal Organization and Morphology of CR Cells
invagination (arrowheads). Scale bar, 400 mm.in Transgenic Mice Overexpressing BDNF
Because one of the major cell types in the marginal zone
is theCR cell, we examined the expression of the CR cell
marker calretinin in sections of E18 transgenic brains the transgenic marginal zone showed clusters of Reelin-
(Figure 7). In contrast to control animals, calretinin label- positive cells flanked by areas devoid of Reelin or calreti-
ing in the marginal zone of transgenic mice was discon- nin staining (Figure 8). Despite the paucity of calretinin
tinuous, with stretches of marginal zone devoid of calret- staining, the marginal zone of transgenic mice contained
inin-positive cell bodies and aggregations of CR cells normal numbers of calretinin-positive neurons.
of abnormal morphology in microgyric sulci (Figure 7D).
In some cases, loose bundles of calretinin-positive fi-
bers entering into the cortical plate were also seen in Aberrant Lamination of the Cerebral Cortex
of nestin±BDNF Transgenic Micetransgenic brains (Figure 7E). Invaginations in the mar-
ginal zone of transgenic mice were filled with calretinin- Finally, we examined cortical organization in transgenic
mice overexpressing BDNF. Immunostaining for micro-positive cell bodies and fibers (Figure 7G). Double label-
ing of calretinin and Reelin in these sections revealed tubule-associated protein-2 (MAP-2), a marker of differ-
entiated neurons, was found in a characteristic layeredcolocalization of these two proteins in the CR cells of
control and transgenic mice (Figure 8). Invaginations of pattern in the cerebral cortex of control E18 mice in
BDNF as a Negative Regulator of Reelin Expression
311
Figure 8. Colocalization of Reelin and Calretinin in Invaginations of the Marginal Zone in Transgenic Mice
Shown are sections through the marginal zone of E18.5 brains stained with anticalretinin (green) and anti-Reelin (red) antibodies. The lower
panels show the merging of the two labelings (calretinin 1 Reelin); double-labeled cells appear yellow. The layer of background signal overlying
the marginal zone in the section of transgenic brain corresponds to autofluorescence from the pial surface, which remained attached to the
brain during preparation of the tissue. Scale bar, 120 mm.
which the marginal zone, the subplate, and an intermedi- central and deeper parts of the cortical plate in E18
normal mice, with few or no cells in the outer layers of theate layer (possibly future layer V) could be clearly distin-
guished (Figures 9A and 9C). In contrast, transgenic cortex or in the marginal zone (Figure 10B). In contrast,
several BrdU-labeled cells in transgenic mice werecerebral cortex showed a more uniform distribution of
MAP-2 labeling without clearly delineated layers (Fig- found in more external cortical layers (Figure 10F), sug-
gesting that these might contain cells originally destinedures 9B and 9D). Although a cortical subplate could be
distinguished in the majority of the transgenic animals for the cortical plate. In both normal and transgenic
animals, the neuroepithelium in the ventricular zone wasexamined by MAP-2 immunostaining, this was often dis-
torted, with pronounced waves and occasional gaps largely devoid of labeled cells (Figures 10A and 10E). In
E18 control animals that had been labeled at E15.5, a(Figure 9B).
The process of cortical lamination was investigated well-defined band of BrdU-labeled cells was found in
the outer layers of the cortical plate close to the marginaldirectly by examining at E18 the fate of cells that had
been pulse labeled with bromodeoxyuridine (BrdU) at zone, while few labeled cells were seen in the neuroepi-
thelium (Figures 10C and 10D). In contrast, fewer BrdU-either E13.5 or E15.5. Labeling with BrdU at E13.5 re-
sulted in a broad band of BrdU-positive cells in the labeled cells, scattered throughout the cortical plate,
Figure 9. Cortical Malformations in Transgenic
Mice Overexpressing BDNF
(A±D) MAP-2 immunohistochemistry in sec-
tions of E18 mouse brain.
(A) In control mice, labeling in the marginal
zone (mz), the subplate (sb), and in an inter-
mediate layer (possibly future layer V) can be
clearly distinguished. Scale bar, 400 mm.
(B) In the cortex of transgenic mice, MAP-2
labeling is uniform, without clearly delineated
layers. Labeling in the subplate (sb) was often
distorted, with pronounced waves and occa-
sional gaps.
(C) High magnification of the view shown in
(A); note the laminar arrangement of cells in
an internal cortical layer (arrow). Scale bar,
400 mm.
(D) High magnification of the view shown in
(B); note the distorted organization of MAP-




Figure 10. Aberrant Cortical Lamination in
nestin±BDNF Mice
Analyses of BrdU-labeled cells in developing
cortex of E18 wild-type and nestin±BDNF
mice. Control (A±D) and transgenic (E±H)
mouse brains were pulse labeled with BrdU
at E13.5 (A, B, E, and F) or E15.5 (C, D, G,
and H) and analyzed at E18.5.
(A, C, E, and G) Neuroepithelium in the ven-
tricular and intermediary migratory zones.
(B, D, F, and H) Cortical plate and marginal
zone. Note the presence of BrdU-labeled
cells in the marginal zone of transgenic mice
that had been labeled at E13.5 (F, arrows).
Note also BrdU-labeled cells in the neuroepi-
thelium and intermediary migratory zone in
transgenic mice that had been labeled at
E15.5 (G). Abbreviation: lv, lateral ventricle.
Scale bar, 200 mm.
were found inE18 transgenic mice that had been labeled and altered morphology and disorganization of CR cells.
These effects, on the other hand, appear to be the resultat E15.5 (Figure 10H), while dense labeling was found
in the neuroepithelium and intermediary migratory zone of the direct action of BDNF on CR cells, which were
found to express TrkB receptors, suggesting that thisin these animals (Figure 10G). These results indicated
a disturbed lamination of the cortical plate in transgenic neurotrophin is capable of affecting several aspects of
the development of these cells, such as gene expres-mice, with several early born neurons reaching out all
the way into the marginal zone, and many later born sion, migration, differentiation, and survival. Although
the level of Reelin expression per cell is lower inneurons that did not migrate into the outer layers of the
cortex and remained instead in deeper layers. These transgenic mice overexpressing BDNF, double-labeling
experiments indicate that the invaginations of the mar-abnormalities are similar to the phenotype of reeler
mice, which aredeficient inReelin expression (Caviness, ginal zone do contain aggregations of Reelin-expressing
CR cells, which as such could represent localized sitesJr. et al., 1988; Ogawa et al., 1995).
of greater Reelin production, as compared with regions
of the marginal zone devoid of invaginations. This local-Discussion
ized concentration of Reelin-expressing cells could per-
haps promote the formation of invaginations in the mar-We have investigated activities of the neurotrophin
BDNF in the developing central nervous system using ginal zone in BDNF-overexpressing mice.
Although less abundant, the heterotopias observedanimal models with either deficient or increased BDNF
signaling, as well as dissociated neuronal cultures, and in nestin±BDNF mice are similar to those described by
Brunstrom et al. (1997) after exogenous administrationfound an unexpected regulatory interaction between
this neurotrophin and the extracellular matrix protein of purified NT-4 to organotypic slice cultures and em-
bryos in utero. Interestingly, that study found exogenousReelin. Reelin expression was found to be under the
negative control of BDNF, both in vivo and after acute application of BDNF to be much less effective than NT-4
at inducing heterotopias (Brunstrom et al., 1997), whichstimulation in vitro, suggesting that Reelin is one direct
effector of this neurotrophin during brain development. could be due to differences in the way cells respond to
these two factors. These authors ruled out increasedReelin, which is required for the normal lamination of
the cortex during embryonic development, is downregu- proliferation or decreased cell death as mechanisms of
generation of NT-4±induced heterotopias and proposedlated during normal postnatal development as cortical
lamination and brain maturation are being completed. that NT-4 and, to a lesser extent, BDNF promoted tan-
gential migration into the marginal zone of excess neu-This downregulation of Reelin expression is dependent
on BDNF, as it was significantly delayed in the absence rons cogenerated with normal marginal zone cells. A simi-
lar mechanism could be the origin of the heterotopiasof this neurotrophin, suggesting that BDNF acts as a
cortical maturation factor. The abnormalities observed seen in the marginal zone of nestin±BDNF transgenic
mice.in the brain of nestin±BDNF transgenic mice may there-
fore be the consequence of the premature expression In addition, the fact that E13 BrdU-labeled cells were
seen in the marginal zone of transgenic mice suggestsof a maturation signal in an otherwise immature brain.
Many of the defects observed in these mice, including that some of the heterotopias observed in these animals
might contain cells originally destined for the corticalaberrant lamination and inverted cortical layering of the
cerebral cortex, resemble the phenotype of reeler mu- plate. In the same study, Brunstrom and colleagues also
reported invaginations of the marginal zone after treat-tant mice, and some of these could therefore be the
result of the profound reduction in Reelin levels pro- ment with NT-4, but not BDNF, of organotypic slice
cultures that were filled with heterotopic collections ofduced by BDNF overexpression. nestin±BDNF mice are
not, however, a precise phenocopy of the reeler muta- cells (Brunstrom et al., 1997). In contrast, invaginations
in nestin±BDNF mice did not appear to contain additionaltion, as they show several other features not present in
reeler mice, including invaginations of the marginal zone cells and were instead rich in calretinin-positive cellular
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small, round, phase-bright process-bearing cells. For immunocyto-processes. The ability of BDNF to induce CR cell aggre-
chemistry, cultures were fixed in 4% paraformaldehyde and pro-gation and marginal zone invaginations in nestin±BDNF
cessed as described. Scoring of staining intensity was done by twomice may be due to the endogenous and prolonged
independent observers who were blind to the treatments made to
expression of this factor in the brains of transgenic ani- the cultures. Cells showing weak but distinct signs of labeling above
mals, compared with the more acute treatments made background were considered as having ªlowº staining intensity;
cells showing saturated levels of staining (maximally stained cells)by Brunstrom and colleagues.
were considered as having ªhighº staining intensity; cells with label-Although developmental downregulation of Reelin ex-
ing intermediate between these two categories were considered aspression during the first 2 postnatal weeks was pre-
having ªmiddleº staining.vented in the absence of BDNF, in the third postnatal
week, cells expressing Reelin appear to require BDNF Histological Techniques
for survival. Death of CR cells at equivalent stages has BrdU labelings were made by injecting pregnant females with 0.15
previously been reported in organotypic slice cultures ml of 1 mg/ml BrdU at the indicated times of gestation. Histological
techniques were otherwise performed as previously described(Del Rio et al., 1996). In the absence of BDNF, the surviv-
(Ringstedt et al., 1997). 33P- and 35S-labeled antisense oligonucleo-ing neurons expressed normal (i.e., reduced) levels of
tides were used for detection of Reelin and TrkB mRNAs, respec-Reelin, suggesting that BDNF acts as a survival factor for
tively, by in situ hybridization. For BDNF in situ hybridization, a
the same subpopulation that normally downregulates 35S-labeled riboprobe complementary to the mouse BDNF coding
Reelin expression during postnatal development. It is sequence was used. The preparation of wild-type and transgenic
therefore possible that, upon the completion of cortical tissues for in situ hybridization was totally comparable. Each
transgenic brain was sectioned simultaneously with a control brain,lamination, this neurotrophin induces a change of fate
so that each glass slide contained one section from a transgenicin a subpopulation of Reelin-positive, BDNF-dependent
brain and an analogous section from a control brain of the sameCR cells. In addition to downregulation of Reelin, BDNF
age. The quantitations in each transgenic brain were normalized
may also induce morphological changes or migration of relative to the levels observed in the control section present in the
these cells, as it does in embryonic CR cells of nestin± same glass slide and were therefore processed simultaneously and
BDNF transgenic mice, and could trigger expression of under the same conditions. Anti-Reelin monoclonal antibodies were
kindly provided by Dr. AndreÂ Goffinet; anti-calretinin polyclonal anti-other gene products. In this context, BDNF has been
bodies were from Swant Swiss Antibodies; anti-MAP-2 polyclonalshown to promote morphological differentiation and ex-
antibodies were from Peninsula Laboratories; anti-BrdU antibodiespression of calbindin in small cortical GABAergic neu-
were from Sigma. Anti-TrkB polyclonal antiserum, directed against
rons (Pappas and Parnavelas, 1997) and expression of the extracellular domain of rat TrkB (TrkB out), was kindly provided
calretinin in hippocampal CR cells (Marty et al., 1996), by Dr. David Kaplan. Marginal zone cell counts (total, calretinin-
as well as phenotypic differentiation of GABAergic neu- positive and Reelin-positive) were determined by counting all cells
in two 908 sectors of marginal zone, from the midline to the mostrons in the striatum (Mizuno et al., 1994).
lateral aspect, in coronal sections at the level of the anterior andIn conclusion, the evidence presented here indicates
posterior hippocampus, respectively.that Reelin is one direct effector of BDNF during postna-
tal brain development. In this regard, BDNF appears to
Image Analysis
function as an intrinsic determinant of cortical matura- The staining intensity of mRNA in tissue sections hybridized in situ
tion, acting as a negative regulator of Reelin expression was assessed using an automated procedure implemented in the
and a signal for CR cell development. We propose that IPLab Spectrum software package (Signal Analytics, Vienna, VA).
For nestin±BDNF transgenic animals and their controls, dark fieldthis neurotrophin is an important component in a devel-
images were taken with a digital camera at constant aperture, expo-opmental program that controls theorganization of lami-
sure, and contrast settings. To separate grains from backgroundnated structures in the mammalian brain.
noise, the images were sharpened by applying an Erode filter fol-
lowed by a Dilate filter, and then segmented into foreground and
background by a threshold that was held constant throughout allExperimental Procedures
measurements. Individual cells were then outlined manually, and
the total foreground area was recorded. These measurements couldTransgenic Mice
not be done blind to the genotype of the animals, owing to theThe generation of BDNF-/- mice has been described previously (Ern-
obvious phenotype of the transgenic animals. The gene-targetedfors et al., 1994b). The nestin±BDNF construct consisted of a region
mice and their littermate controls were assessed independently byextending 5.8 kb upstream from the initiation codon of the mouse
the same procedure, except that the Erode/Dilate steps were re-nestin gene (Zimmerman et al., 1994), followed by a 1 kb fragment
placed by a single application of the 3 x 3 Sharpen filter, whichfrom the fifth exon of the mouse BDNF gene containing the complete
appeared better at separating the grains from the background.BDNF protein coding sequence, a 300 bp SV40 polyadenylation
These measurements were done by an observer who was blind tosignal, and 5.4 kb of nestin gene downstream sequence, including
the genotype of the mice. Measurements over unstained cells usingintrons 1, 2, and 3 (Zimmerman et al., 1994). The construct was
the same procedure were used to correct for background.injected into fertilized mouse oocytes that were subsequently trans-
planted into pseudopregnant females. Transgenic embryos were
RNase Protection Assay and Enzyme Immunoassayidentified by PCR.
Cultures were homogenized in guanidine isothiocyanate (GITC) and
b-mercaptoethanol. For RNA extraction, 1/10 volume of 2 M sodium
acetate (pH 4.0) was added, followed by phenol/chloroform extrac-Cell Culture
Dissociated cultures of embryonic rat cortex were prepared as de- tion and ethanol precipitation. A riboprobe was made from a cDNA
fragment of the mouse reelin gene (GenBank accession numberscribed previously (Lu and DiCicco-Bloom, 1997), with the exception
that embryos were taken on the sixteenth day of gestation, and AA268883) with a kit of reagents from Promega. RPA was performed
on 5 mg of the total RNA with a kit of reagents from Ambion, ac-cells were plated at high density (1.5 3 106 cells/cm2) to minimize
death. Recombinant neurotrophins BDNF, NT-3, or NT-4(Regeneron cording to the instructions of the manufacturer. RPA gels were ana-
lyzed in a Storm 840 phosphorimager with ImageQuant softwarePharmaceuticals) were added at 50 ng/ml at the time of plating.
Cultures were maintained in serum-free, defined media (N2) for 12 (Molecular Dynamics). Enzyme immunoassay for BDNF was per-
formed as previously described (Nawa et al., 1995).hr for 2 or 5 days; at these times, the cultures consisted of .90%
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